Fairmount Funds Management LLC - 31 Dec 2024 SCHEDULE 13G/A Report for Astria Therapeutics, Inc. Common Stock, par value $0.001 per share (ATXS)

Filing Manager: Fairmount Funds Management LLC
Reporting Manager: Fairmount Funds Management LLC
Security: Astria Therapeutics, Inc. Common Stock, par value $0.001 per share
Symbol: ATXS
Shares outstanding: 59,283,202 shares
Disclosed Ownership: 5,869,037 shares
Ownership: 9.9%
Form type: SCHEDULE 13G/A
Filing time: 14 Feb 2025, 15:45:06 UTC
Date of event: 31 Dec 2024
Next filing: 15 Oct 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Fairmount Funds Management LLC	9.9%	5,869,037	0	5,869,037	/s/ Peter Harwin	Peter Harwin, Managing Member
Fairmount Healthcare Fund II GP LLC	9.9%	5,869,037	0	5,869,037	/s/ Peter Harwin	Peter Harwin, Managing Member